BEAMSTART Logo

Hanwha to re-enter biopharma market, targeting biomaterials

Korea Economic Daily LogoKorea Economic Daily2 mo ago

Hanwha to re-enter biopharma market, targeting biomaterials - Korea Economic Daily

Quick Summary:

South Korea’s Hanwha Group will re-enter the biopharmaceutical market to become the country’s sole producer of tris buffers, a key reagent used for medical experiments such as generic DNA tests, according to industry sources on Tuesday.

LESS CROWDEDIndustry observers said tris buffer manufacturing technology will fit well with Hanwha Group's strengths in handling chemicals such as ammonia and help the conglomerate build a foothold in the pharmaceutical market.

Its holding company Hanwha Corp.will soon announce a plan to invest 110 billion won ($84 million) to build two tris buffer plants, one each in South Korea and the US.


More Pictures

Hanwha to re-enter biopharma market, targeting biomaterials - Korea Economic Daily (Picture 1)Hanwha to re-enter biopharma market, targeting biomaterials - Korea Economic Daily (Picture 2)Hanwha to re-enter biopharma market, targeting biomaterials - Korea Economic Daily (Picture 3)Hanwha to re-enter biopharma market, targeting biomaterials - Korea Economic Daily (Picture 4)

or

Article Details

Category: Economy

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2023-12-05 @ 18:06:39 (2 months ago)

News Timezone: GMT +8:00

News Source URL: kedglobal.com

Language: English

Article Length: 484 words

Reading Time: 3 minutes read

Sentences: 24 lines

Sentence Length: 21 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Korea Economic Daily

News ID: 19103429

View Article Analysis

About Korea Economic Daily

Korea Economic Daily Logo

Main Topics: Economy

Official Website: kedglobal.com

Update Frequency: 21 posts per day

Year Established: 1964

Headquarters: South Korea

News Last Updated: ago

Coverage Areas: South Korea

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #91

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "Hanwha to re-enter biopharma market, targeting biomaterials" has 484 words across 24 sentences, which will take approximately 3 - 5 minutes for the average person to read.

Which news outlet covered this story?

The story "Hanwha to re-enter biopharma market, targeting biomaterials" was covered 2 months ago by Korea Economic Daily, a news publisher based in South Korea.

How trustworthy is 'Korea Economic Daily' news outlet?

Korea Economic Daily is a fully independent (privately-owned) news outlet established in 1964 that covers mostly economy news.

The outlet is headquartered in South Korea and publishes an average of 21 news stories per day.

It's most recent story was published ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #19103429
  • URL: https://beamstart.com/news/hanwha-to-re-enter-biopharma-17017674707592

BEAMSTART brings you the latest news, databases, and jobs from all around the world on startups, technology, and business. Stay updated with industry news, plug-in to exciting community events, and discover incredible career opportunities with the world's most innovative companies.

© Copyright 2024 BEAMSTART. All Rights Reserved.